The University of Southampton
University of Southampton Institutional Repository

A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer’s disease

Kemp, P.M., Holmes, C., Hoffmann, S., Wilkinson, S., Zivanovic, M., Thom, J., Bolt, L., Fleming, J.S. and Wilkinson, D.G. (2003) A randomised placebo controlled study to assess the effects of cholinergic treatment on muscarinic receptors in Alzheimer’s disease Journal of Neurology Neurosurgery and Psychiatry, 74, (11), pp. 1567-1570. (doi:10.1136/jnnp.74.11.1567).

Record type: Article


Objective:to determine the effects of cholinergic treatment on the muscarinic receptor in patients with Alzheimer’s disease.
Methods:12 patients with mild to moderate Alzheimer’s disease and six controls were studied. The patients underwent ADAS-COG psychometric assessment and SPECT brain imaging with 123I quinuclidinyl benzilate (QNB), to demonstrate the postsynaptic muscarinic M1 receptor, before being randomised in a double blind study to receive either an acetylcholinesterase inhibitor (donepezil) or placebo for four months. Following this, the ADAS-COG and the 123I-QNB receptor scan were repeated. The controls were imaged on one occasion only. All image analyses were undertaken using SPM99.
Results:123I-QNB imaging showed a significant relation between baseline psychometric impairment and deficits on scanning. Both placebo and actively treated groups had reductions in 123I-QNB uptake. Greater reductions in receptor binding were demonstrated in the placebo group than in those receiving active treatment. Intraindividual reproducibility of the 123I-QNB imaging technique appeared highly robust.
Conclusions:the results suggest that 123I-QNB uptake is better preserved in Alzheimer’s disease patients on cholinergic treatment than on placebo. Cholinergic treatment may play a neuroprotective role. Sequential 123I-QNB imaging seems to be a powerful tool in monitoring the response of these receptors to disease modifying treatments.

Full text not available from this repository.

More information

Published date: 2003
Additional Information: Short Report
Keywords: alzheimer’s disease, quinuclidinyl benzilate, spect


Local EPrints ID: 25707
ISSN: 0022-3050
PURE UUID: 431b8a75-e1c2-4251-9de5-0a853aba8099

Catalogue record

Date deposited: 24 Apr 2006
Last modified: 17 Jul 2017 16:09

Export record



Author: P.M. Kemp
Author: C. Holmes
Author: S. Hoffmann
Author: S. Wilkinson
Author: M. Zivanovic
Author: J. Thom
Author: L. Bolt
Author: J.S. Fleming
Author: D.G. Wilkinson

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton:

ePrints Soton supports OAI 2.0 with a base URL of

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.